Mupirocine Infectopharm

Mupirocin, the active ingredient in Mupirocine Infectopharm, is an antibiotic presented as an unknown/unknown for nasal use. It is employed to eradicate nasal colonisation of Staphylococcus aureus, including methicillin‑resistant strains, in patients who require decolonisation.

GNH USA supplies Mupirocine Infectopharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mupirocin is a topical antibacterial indicated for bacterial colonisation and skin infections caused by susceptible organisms. - Nasal decolonisation of Staphylococcus aureus (including MRSA): eliminates carrier state to reduce infection risk. - Impetigo (non‑bullous): treats superficial skin infection caused by Staphylococcus or Streptococcus species. - Secondary bacterial skin infections: controls infection in minor cuts, abrasions or eczema lesions.

Mupirocin is generally well tolerated, but local and systemic reactions can occur.

Common Side Effects: - Nasal irritation: mild burning or stinging sensation. - Itching or pruritus at the application site. - Dryness of nasal mucosa. - Sneezing or mild rhinorrhoea. - Headache. - Transient erythema.

Serious or Rare Side Effects: - Allergic reaction: rash, urticaria, or angioedema. - Anaphylaxis: severe, potentially life‑threatening hypersensitivity. - Severe dermatitis or contact dermatitis. - Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Secondary infection with resistant organisms. - Systemic absorption leading to hepatic or renal effects (very rare).

Before using Mupirocine Infectopharm, consider the following safety measures. - Assess colonisation status: confirm Staphylococcus aureus carriage before treatment. - Hypersensitivity: avoid in patients with known allergy to mupirocin or formulation excipients. - Prescription use only: apply exactly as directed by a healthcare professional. - Monitor for worsening infection: seek medical advice if signs of spreading or systemic infection appear. - Storage: Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Mupirocin has limited systemic interactions, but certain combinations may affect safety or efficacy.

Major Interactions (Avoid): - Concurrent use with other nasal antibiotics: may increase local irritation or reduce effectiveness. - Use with otic or ophthalmic preparations containing preservatives: risk of additive toxicity.

Moderate Interactions (Monitor Closely): - Systemic antibiotics that alter normal flora: may affect colonisation dynamics. - Antifungal nasal agents: monitor for combined mucosal irritation. - Immunosuppressive therapy: observe for delayed wound healing or infection spread.